Advertisement
Screener

NIAGEN BIOSCIENCE, INC. (NAGE) Deferred Federal Income Tax Expense (Benefit)

NIAGEN BIOSCIENCE, INC. Deferred Federal Income Tax Expense (Benefit)

NIAGEN BIOSCIENCE, INC. (NAGE) reported Deferred Federal Income Tax Expense (Benefit) of $0 for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-04.

Financial Statements › Expense Statement › Income Tax

us-gaap:DeferredFederalIncomeTaxExpenseBenefit · last filed 2025-03-04

  • NIAGEN BIOSCIENCE, INC. deferred federal income tax expense (benefit) for fiscal 2024 was $0.00.
  • NIAGEN BIOSCIENCE, INC. deferred federal income tax expense (benefit) for fiscal 2023 was $0.00.
  • NIAGEN BIOSCIENCE, INC. deferred federal income tax expense (benefit) for fiscal 2017 was $0.00.
  • NIAGEN BIOSCIENCE, INC. deferred federal income tax expense (benefit) for fiscal 2016 was $0.00.
Period endDeferred Federal Income Tax Expense (Benefit) 12 month
2024-12-31$0.00
10-K · filed 2025-03-04
2023-12-31$0.00
10-K · filed 2025-03-04
2017-12-30$0.00
10-K · filed 2018-03-15
2016-12-31$0.00
10-K · filed 2018-03-15
2016-01-02$0.00
10-K · filed 2018-03-15
2015-01-03$0.00
10-K · filed 2017-03-16

Similar stocks

Stock NameCountryMarket CapPE Ratio
USANA HEALTH SCIENCES INC (USNA)United States$0.264B-17.90
FITLIFE BRANDS, INC. (FTLF)United States$0.087B16.59
Canopy Growth Corp (CGC)$0.395B
MANNATECH INC (MTEX)United States$0.014B
NATURAL ALTERNATIVES INTERNATIONAL INC (NAII)United States$0.011B-1.16
Synergy CHC Corp. (SNYR)United States$0.001B
Functional Brands Inc. (MEHA)United States$0.001B
Tilray Brands, Inc. (TLRY)United States$0.554B-5.97
Cronos Group Inc. (CRON)$1.223B
Definium Therapeutics, Inc. (DFTX)United States$4.931B-17.87